About Us
Company History
Vision & Values
Services
At a Glance
In vitro
DMPK & Pharmacology
Physicochemical Properties
Chemical Stability
In vitro
Binding
Metabolic Stability
Permeability & Transporter Services
Reaction Phenotyping
CYP Inhibition
CYP Induction
Pharmacology Assay Development
Customised Laboratory Services
PK, Bioanalysis & Metabolite Identification
Bioanalysis Overview
Bioanalysis Services
Metabolite Identification
Pharmacokinetics (PK)
Metabolite Bulk-Up & Isolation (mg to g)
Modelling & Simulation
ADME Packages
Pharmacokinetics
Absorption
Oral Exposure
Human PK & Dose Prediction
Formulation Services
Due Diligence
Hit/Lead Compounds
Clinical Candidate
Latest
Blog
Events
News
Partners
Axis BioServices
BioAscent
Charnwood Molecular
Medicines Discovery Catapult
Reach Separations
Saretius
TherapeutAix
Meet The Team
Resources
Articles
Posters
Presentations
Publications
Videos
Contact Us
Join Us
About Us
Company History
Vision & Values
Services
At a Glance
In vitro
DMPK & Pharmacology
Physicochemical Properties
Chemical Stability
In vitro
Binding
Metabolic Stability
Permeability & Transporter Services
Reaction Phenotyping
CYP Inhibition
CYP Induction
Pharmacology Assay Development
Customised Laboratory Services
PK, Bioanalysis & Metabolite Identification
Bioanalysis Overview
Bioanalysis Services
Metabolite Identification
Pharmacokinetics (PK)
Metabolite Bulk-Up & Isolation (mg to g)
Modelling & Simulation
ADME Packages
Pharmacokinetics
Absorption
Oral Exposure
Human PK & Dose Prediction
Formulation Services
Due Diligence
Hit/Lead Compounds
Clinical Candidate
Latest
Blog
Events
News
Partners
Axis BioServices
BioAscent
Charnwood Molecular
Medicines Discovery Catapult
Reach Separations
Saretius
TherapeutAix
Meet The Team
Resources
Articles
Posters
Presentations
Publications
Videos
Contact Us
Join Us
XenoGesis shortlisted as national finalist for Export Achievement
XenoGesis expands bioanalytical capacity with the purchase of two new mass specs
2019 Round up
Rachel Hemsley celebrates two years at XenoGesis
XenoGesis take home Medlink Export Achievement Award
Ada Lovelace Day 2019
Richard Weaver to join panel at Pharma Integrates
XenoGesis exhibiting at ELRIG Drug Discovery 2019
Richard Weaver shortlisted in IoD Director of the Year Awards 2019
Innovative candidate drug against malaria offers considerable potential
Posts navigation
1
2
Next Page
